
Intercom
$62.76
Source:$2.56 (4.25%)past six months
Intercom Valuation
Follow estimated valuations, share price trends, and company updates for Intercom.
About Intercom
Intercom is a customer communication platform that provides businesses with tools to enhance customer engagement and support through AI-driven solutions. Intercom focuses on delivering exceptional customer experiences across various channels.
| Co-Founder | Des Traynor |
| Chairman | Eoghan McCabe |
| CEO | Eoghan McCabe |
| President | Archana Agrawal |
| CFO | Dan Griggs |
| CTO | Darragh Curran |
| Headquarters | San Francisco, CA |
| Founded | 2011 |
| Sector | Enterprise Software |
Intercom Funding History
| Financing Round | Date | Amount |
|---|---|---|
| Series D | Mar 1, 2018 | $125M |
| Series C-1 | Dec 21, 2015 | $50M |
| Series C | Aug 26, 2015 | $35M |
| Series B | Jan 22, 2014 | $23M |
| Series A | Jun 19, 2013 | $6M |
Intercom lead investors
- Bessemer Venture Partners
- Freestyle Capital
- Google Ventures
- ICONIQ
- Index Ventures
- Individuals
- Jack Dorsey
- Kleiner Perkins Caufield & Byers
- Mark Zuckerberg
- Social Capital Partnership
FAQ
Frequently asked questions
Intercom's estimated secondary market share price is $62.76 as of September 2026.
Intercom's last official round, Series D, was for $125M.
Intercom's last known funding was on Mar 1, 2018 for $125M.
Intercom's major investors are Bessemer Venture Partners, Freestyle Capital, Google Ventures, ICONIQ, Index Ventures, Individuals, Jack Dorsey, Kleiner Perkins Caufield & Byers, Mark Zuckerberg, Social Capital Partnership.
As of November 11, 2026, Intercom is not yet publicly traded.
Private companies
OpenAIOPEA+50.04%
StripeSTRI+2.09%
DatabricksDABR+27.87%
AnthropicANTH0.00%
PerplexityPERP+27.84%
NeuralinkNEUL+44.67%
AndurilADUI+12.52%
Intercom Valuation
Follow estimated valuations, share price trends, and company updates for Intercom.
Private companies
OpenAIOPEA+50.04%
StripeSTRI+2.09%
DatabricksDABR+27.87%
AnthropicANTH0.00%
PerplexityPERP+27.84%
NeuralinkNEUL+44.67%
AndurilADUI+12.52%